Intermedin Is a Calcitonin/Calcitonin Gene-related Peptide Family Peptide Acting through the Calcitonin Receptor-like Receptor/Receptor Activity-modifying Protein Receptor Complexes
Open accessThe DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
Calcitonin, calcitonin gene-related peptide (CGRP), adrenomedullin (ADM), and amylin belong to a unique group of peptide hormones important for homeostasis in diverse tissues. Calcitonin is essential for calcium balance, whereas CGRP and ADM are important for neurotransmission and cardiovascular and respiratory regulation. Based on phylogenetic analysis, we identified intermedin as a novel member of the calcitonin/CGRP peptide family. Analysis of intermedin expression indicated that intermedin is expressed primarily in the pituitary and gastrointestinal tract. Intermedin increased cAMP production in SK-N-MC and L6 cells expressing endogenous CGRP receptors and competed with labeled CGRP for binding to its receptors in these cells. In addition, treatment of 293T cells expressing recombinant calcitonin receptor-like receptor (CRLR) and one of the three receptor activity-modifying proteins (RAMPs) showed that a CRLR/RAMP receptor complex is required for intermedin signaling. In contrast to CGRP and ADM, which exhibited a preferential stimulation of CRLR when co-expressed with RAMP1 and RAMP2 or RAMP3, respectively, intermedin represents a nonselective agonist for the RAMP coreceptors. In vivo studies demonstrated that intermedin treatment led to blood pressure reduction in both normal and spontaneously hypertensive rats via interactions with the CRLR/RAMP receptor complexes. Furthermore, in vivo treatment in mice with intermedin led to suppression of gastric emptying activity and food intake. Thus, identification of intermedin as a novel member of the calcitonin/CGRP peptide family capable of signaling through CRLR/RAMP receptor complexes provides an additional player in the regulation of peripheral tissues by CRLR and will allow development of new therapeutic agents for pathologies associated with diverse vascular and gastrointestinal disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In 2004, two groups discovered the mammalian gene ADM2, which encodes a peptide with high similarity to adrenomedullin, and was named intermedin or adrenomedullin 2 (177, 195).”
From The Activity of Peptides of the Calcitonin Family in Bone (2019) · cites this paper as [177]
In the citing paper
“Roh et al. found that, in the rat, intermedin is primarily expressed in the pituitary and gastrointestinal tract and showed that intraperitoneal administration of intermedin decreased blood pressure in both normal and spontaneously hypertensive rats (98, 177).”
From The Activity of Peptides of the Calcitonin Family in Bone (2019) · cites this paper as [177]
In the citing paper
“Later studies have shown that CRLR/RAMP complex also functions as receptor for intermedin, which binds in a nonselective manner to either of the three RAMPs/CRLR dimers (177).”
From The Activity of Peptides of the Calcitonin Family in Bone (2019) · cites this paper as [177]
Citations
Cites
Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing
Rosenfeld, M. G., Mermod, J.-J., Amara, S. G., Swanson, L. W., Sawchenko, P. E., Rivier, J., Vale, W. W., & Evans, R. M. (1983) · Nature · doi:10.1038/304129a0 · Cited by 2,302
Adrenomedullin: A Novel Hypotensive Peptide Isolated from Human Pheochromocytoma
Kitamura, K., Kangawa, K., Kawamoto, M., Ichiki, Y., Nakamura, S., Matsuo, H., & Eto, T. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.1451 · Cited by 2,192
RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor
McLatchie, L. M., Fraser, N. J., Main, M. J., Wise, A., Brown, J., Thompson, N., Solari, R., Lee, M. G., & Foord, S. M. (1998) · Nature · doi:10.1038/30666 · Cited by 2,134
Amara, S. G., Jonas, V., Rosenfeld, M. G., Ong, E. S., & Evans, R. M. (1982) · Nature · doi:10.1038/298240a0 · Cited by 2,105
Reyes, T. M., Lewis, K., Perrin, M. H., Kunitake, K. S., Vaughan, J., Arias, C. A., Hogenesch, J. B., Gulyas, J., Rivier, J., Vale, W. W., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051626398 · Cited by 887
Poyner, D. R., Sexton, P. M., Marshall, I., Smith, D. M., Quirion, R., Born, W., Muff, R., Fischer, J. A., & Foord, S. M. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.233 · Cited by 804
Activation of Orphan Receptors by the Hormone Relaxin
Hsu, S. Y., Nakabayashi, K., Nishi, S., Kumagai, J., Kudo, M., Sherwood, O. D., & Hsueh, A. J. W. (2002) · Science · doi:10.1126/science.1065654 · Cited by 786
Self-citationHsu, S. Y., & Hsueh, A. J. W. (2001) · Nature Medicine · doi:10.1038/87936 · Cited by 650
Self-citationCloning and Characterization of cDNA Encoding a Precursor for Human Adrenomedullin
Kitamura, K., Sakata, J., Kangawa, K., Kojima, M., Matsuo, H., & Eto, T. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.1881 · Cited by 605
Christopoulos, G., Perry, K. J., Morfis, M., Tilakaratne, N., Gao, Y., Fraser, N. J., Main, M. J., Foord, S. M., & Sexton, P. M. (1999) · Molecular Pharmacology · doi:10.1124/mol.56.1.235 · Cited by 486
Research works printed but not linked: 6
- Copp, 1994, Clin. Investig. Med., 17, 268
- Mulder, 2000, Am. J. Physiol., 278, E684
- Chiba, 1989, Am. J. Physiol., 256, E331
- Eguchi, 1994, Endocrinology, 135, 2454, 10.1210/endo.135.6.7988431 · doi:10.1210/endo.135.6.7988431 · Paper page
- Reidelberger, 2002, Am. J. Physiol., 282, R1395
- Meeran, 1997, J. Clin. Endocrinol. Metab., 82, 95
Cited by
Items 201–300 of 446
Gu, C., Park, S., Seok, J., Jang, H. Y., Bang, Y. J., & Kim, G. I. J. (2020) · Biology of Reproduction · doi:10.1093/biolre/ioaa178 · Cited by 21
“19 of three RAMPs (RAMP1, RAMP2, or RAMP3) and that effects of ADM are mediated by CRLR and RAMP2 or RAMP3 whereas effects of ADM2 are mediated by CRLR and RAMP3 [14, 18, 30].”
BackgroundIttner, L. M., Kerstin, S., Kunz, T. H., Muff, R., Husmann, K., Grimm, C., Hafezi, F., Lang, K. S., Kurrer, M. O., Götz, J., et al. (2007) · Clinical Science · doi:10.1042/cs20070163 · Cited by 21
Intermedin ameliorates IgA nephropathy by inhibition of oxidative stress and inflammation
Wang, Y., Tian, J., Guo, H., Mi, Y., Zhang, R., & Li, R. (2015) · Clinical and Experimental Medicine · doi:10.1007/s10238-015-0351-8 · Cited by 21
Sun, J. Y., Ren, X., Kang, Y., Dai, H., Ding, L., Tong, N., Zhu, G., & Zhou, Y. (2018) · Neuroscience Bulletin · doi:10.1007/s12264-018-0292-9 · Cited by 20
“IMD can bind nonselectively to all three complexes [15].”
BackgroundA novel CGRP ‐neutralizing S piegelmer attenuates neurogenic plasma protein extravasation
Hoehlig, K., Johnson, K. W., Pryazhnikov, E., Maasch, C., Clemens‐Smith, A., Purschke, W. G., Vauléon, S., Buchner, K., Jarosch, F., Khiroug, L., et al. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13110 · Cited by 20
“NOX-L41 selectively binds and inhibits CGRP The calcitonin family consists of six structurally related peptides, some of them sharing high sequence homology (Roh et al., 2004).”
BackgroundRNA sequencing reveals retinal transcriptome changes in STZ-induced diabetic rats
Liu, Y., Lian, Z., Liu, G., Zhou, H., & YANG, H.-J. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.4793 · Cited by 22
“Adrenomedullin 2 (ADM2) or intermedin (IMD) is a member of the CGRP family (31,32).”
Jolly, L., March, J., Kemp, P. A., Bennett, T. M., & Gardiner, S. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00306.x · Cited by 19
“In the original description (Roh et al., 2004), the mature peptides identified were the 47 amino acid prepro-IMD101–147 (IMD1–47, also known as IMD long) and the 40 amino acid prepro-IMD108–147 (IMD8–47, also known as IMD short).”
BackgroundResultInfluentialWang, D., Ruan, L., Hong, Y., Chabot, J., & Quirion, R. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.10.006 · Cited by 19
Zeng, Q., Yuan, Y., Wang, X., Wu, H., Fan, L., Qi, Y. F., Tang, C., Cai, Y., & Pan, C. S. (2008) · Peptides · doi:10.1016/j.peptides.2008.10.021 · Cited by 19
Bell, D., Campbell, M., Ferguson, M., Sayers, L., Donaghy, L., O’Regan, A., Jewhurst, V., & Harbinson, M. (2011) · The Journal of Physiology · doi:10.1113/jphysiol.2011.221895 · Cited by 18
“Cleavage sites demarcated by paired basic amino acids at various positions within the mammalian prepro-IMD precursor yield a series of peptides of varying length, namely IMD1−53, IMD1−47 and IMD8−47 (Roh et al. 2004; Yang et al. 2005).”
BackgroundPregnancy Increases Relaxation in Human Omental Arteries to the CGRP Family of Peptides1
Dong, Y., Betancourt, A., Chauhan, M., Balakrishnan, M. P., Lugo, F., Anderson, M. L., Espinoza, J., Fox, K. A., Belfort, M. A., & Yallampalli, C. (2015) · Biology of Reproduction · doi:10.1095/biolreprod.115.135665 · Cited by 18
“It is well accepted that coexpression of CALCRL with RAMP1 forms a CALCB receptor, whereas RAMP2 or RAMP3 produces an ADM receptor, and coexpression of CALCRL with any of the three RAMPs mediates ADM2 signaling.”
BackgroundInfluentialThe Role of the Calcitonin Peptide Family in Prostate Cancer and Bone Metastasis
Warrington, J. I., Richards, G. O., & Wang, N. (2017) · Current Molecular Biology Reports · doi:10.1007/s40610-017-0071-9 · Cited by 19
Hirose, T., Totsune, K., Mori, N., Mori, T., Morimoto, R., Metoki, H., Asayama, K., Kikuya, M., Ohkubo, T., Kohzuki, M., et al. (2010) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00679.2009 · Cited by 18
“The CGRP family has multiple biological effects, including potent vasodilation (CGRP and AM), reduced nutrient intake (amylin), and decreased bone resorption (calcitonin) (19).”
BackgroundInfluentialThe human endolymphatic sac expresses natriuretic peptides
Møller, M. N., Kirkeby, S., Vikeså, J., Nielsen, F. C., & Cayé‐Thomasen, P. (2017) · The Laryngoscope · doi:10.1002/lary.26074 · Cited by 18
Guo, X., Yuan, J., Li, M., Wang, M., & Lv, P. (2020) · Journal of Molecular Neuroscience · doi:10.1007/s12031-020-01697-3 · Cited by 18
CGRP: a Multifunctional Neuropeptide
Russo, A. F., & Dickerson, I. M. (2006) · Springer eBooks · doi:10.1007/0-387-30395-2_19 · Cited by 18
Xiao, F., Li, H., Feng, Z., Huang, L., Kong, L., Li, M., Wang, D., Liu, F., Zhu, Z., Wei, Y., et al. (2021) · Scientific Reports · doi:10.1038/s41598-020-80066-x · Cited by 17
Endosomal proteolysis regulates calcitonin gene‐related peptide responses in mesenteric arteries
McNeish, A. J., Roux, B. T., Aylett, S., MaassenVanDenBrink, A., & Cottrell, G. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02129.x · Cited by 17
“The latter increase (CGRP, 1 mM) probably reflecting the ability of CGRP to activate adrenomedullin receptors at high concentrations (Roh et al., 2004).”
BackgroundThe novel tumor angiogenic factor, adrenomedullin-2, predicts survival in pancreatic adenocarcinoma
Hollander, L. L., Guo, X., Salem, R. R., & Cha, C. H. (2015) · Journal of Surgical Research · doi:10.1016/j.jss.2014.11.002 · Cited by 17
Roles of CLR/RAMP Receptor Signaling in Reproduction and Development
Chang, C. L., & Hsu, S. Y. (2013) · Current Protein and Peptide Science · doi:10.2174/13892037113149990056 · Cited by 21
Self-citationVascular and molecular pharmacology of the metabolically stable CGRP analogue, SAX
Sheykhzade, M., Abdolalizadeh, B., Koole, C., Pickering, D. S., Dreisig, K., Johansson, S. E., Abboud, B. K., Dreier, R., Berg, J. O., Jeppesen, J., et al. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.04.007 · Cited by 17
The Calcitonin/Calcitonin Gene-Related Peptide Family in Invertebrate Deuterostomes
Sekiguchi, T. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00695 · Cited by 18
Induction of adrenomedullin 2/intermedin expression by thyroid stimulating hormone in thyroid
Nagasaki, S., Fukui, M., Asano, S., Ono, K., Miki, Y., Araki, S.-I., Isobe, M., Nakashima, N., Takahashi, K., Sasano, H., et al. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.07.008 · Cited by 16
Qiao, X., Wang, L., Wang, Y., Su, X., Qiao, Y., Fan, Y., & Peng, Z. (2017) · BMC Nephrology · doi:10.1186/s12882-017-0659-6 · Cited by 16
“Intermedin [IMD, also known as adrenomedullin-2 (ADM-2)] is a novel member of the calcitonin/calcitonin gene-related peptide family [6].”
Adrenomedullin disulfide bond mimetics uncover structural requirements for AM1 receptor activation
Fischer, J., Schönauer, R. A.-R., Els‐Heindl, S., Bierer, D. E., Koebberling, J., Riedl, B., & Beck‐Sickinger, A. G. (2019) · Journal of Peptide Science · doi:10.1002/psc.3147 · Cited by 17
Receptor Activity Modifying Proteins and Their Potential as Drug Targets
Wootten, D. L., Simms, J., Hay, D. L., Christopoulos, A., & Sexton, P. M. (2010) · Progress in molecular biology and translational science · doi:10.1016/s1877-1173(10)91003-x · Cited by 16
“Intermedin (AM2) displays high affinity for the CLR complexed with either RAMP1, 2, or 3 and ProCT interacts with the CGRP receptor (CLR/RAMP1).(17,18) Unlike the CLR, the CTR will traffick efficiently to the cell surface and also bind to CT in the absence of RAMPs.”
BackgroundQiao, X., Wang, L., Wang, Y., Zhao, N., Zhang, R., Han, W., & Peng, Z. (2015) · Nephrology · doi:10.1111/nep.12520 · Cited by 16
“As a member of the CGRP family, IMD is closely related to ADM.(8) IMD and ADM share the CRLR/RAMP receptor system and may, therefore, have similar biological actions.”
BackgroundInfluentialThe Prognostic Value of Intermedin in Patients with Breast Cancer
Lu, Y., Zhong, J.-B., Wang, H., Yu, X., & Li, Z. (2015) · Disease Markers · doi:10.1155/2015/862158 · Cited by 16
“Similar to adrenomedullin, IMD signals through the calcitonin receptor-like receptor/receptor activity modifying protein complexes and performs vasodilatory and hypotensive actions, with potencies similar to or greater than adrenomedullin [26–28].”
BackgroundCigarette Smoke-Induced Placental Adrenomedullin Expression and Trophoblast Cell Invasion
Kraus, D. M., Feng, L., Heine, R. P., Brown, H. L., Caron, K. M., Murtha, A. P., & Grotegut, C. A. (2013) · Reproductive Sciences · doi:10.1177/1933719113488456 · Cited by 16
“Furthermore, cigarette smoke enhanced lung cancer growth by activating the AHR, which increased cellular production of AM.”
BackgroundInfluentialYuan, Y., Wang, X., Zeng, Q., Wu, H., Yongfen, Q., & Tang, C. (2012) · 老年心脏病学杂志:英文版 · doi:10.3724/sp.j.1263.2012.00017 · Cited by 16
Ranjbaran, A., Nejabati, H. R., Ghasemnejad, T., Latifi, Z., Hamdi, K., Hajipour, H., Raffel, N., Bahrami‐Asl, Z., Hakimi, P., Mihanfar, A., et al. (2019) · Geburtshilfe und Frauenheilkunde · doi:10.1055/a-0764-4765 · Cited by 16
“ADM2 acts through the G protein-coupled receptor (GPCR) and calcitonin receptor-like receptor (CRLR) together with one of three receptor activity-modifying proteins (RAMP1, RAMP2, and RAMP3) [15].”
Altered Expression of Adrenomedullin 2 and its Receptor in the Adipose Tissue of Obese Patients
Kim, J., Lee, S. K., Kim, D.-U., Choe, H., Jang, Y. J., Park, H. S., Kim, J.-H., Hong, J. P., Lee, Y. J., & Heo, Y. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz066 · Cited by 16
Adrenomedullin as a Growth and Cell Fate Regulatory Factor for Adult Neural Stem Cells
Martínez-Herrero, S., Larráyoz, I. M., Ochoa‐Callejero, L., Garcı́a-Sanmartı́n, J., & Martı́nez, A. (2012) · Stem Cells International · doi:10.1155/2012/804717 · Cited by 15
“Intermedin, also named adrenomedullin 2, has also been identified as a novel member of this family [12, 13].”
BackgroundWang, Y., Li, R., Qiao, X., Tian, J., Su, X., Wu, R.-P., Zhang, R., Zhou, X., Li, J., & Shan, S. (2013) · Nephrology · doi:10.1111/nep.12114 · Cited by 15
“Intermedin/adrenomedullin 2 (IMD/ADM2), also called adrenomedullin 2 (ADM-2), is a novel member of the calcitonin gene-related peptide (CGRP) superfamily and shares approximately 30% amino acid sequence homology with ADM.(1,2) Similar to ADM, IMD/ADM2 is localized in the tissues of the cardiovascular and renal systems…”
BackgroundFan, S., Qi, D., Yu, Q., Tang, X., Wen, X., Wang, D., & Deng, X. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106951 · Cited by 15
Anand, A., Sharma, A., Ravins, M., Biswas, D., Ambalavanan, P., Lim, K. X. Z., Tan, R. Y. M., Johri, A. K., Tirosh, B., & Hanski, E. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abd7465 · Cited by 15
“CGRP is produced by the adrenomedullin 2 (ADM2) gene product that is proteolytically processed to biologically active multifunctional peptides (60).”
BackgroundHikosaka, T., Tsuruda, T., Nagata, S., Kuwasako, K., Tsuchiya, K., Hoshiko, S., Inatsu, H., Chijiiwa, K., & Kitamura, K. (2011) · Peptides · doi:10.1016/j.peptides.2011.07.012 · Cited by 15
Bell, D., Gordon, B. J., Lavery, A., Megaw, K., Kinney, M. O., & Harbinson, M. (2016) · Peptides · doi:10.1016/j.peptides.2015.12.003 · Cited by 15
Sun, J. Y., Qian, P., Kang, Y., Dai, H., Wang, F., Wang, H., Zhou, Y., Gao, Q., & Zhou, Y. (2020) · Neuropeptides · doi:10.1016/j.npep.2020.102109 · Cited by 15
Huang, L., Wang, D., Feng, Z., Zhao, H., Xiao, F., Wei, Y., Zhang, H., Li, H., Kong, L., Li, M., et al. (2020) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-20-0619 · Cited by 15
“Intermedin [IMD; also named Adrenomedullin 2 (ADM2)] is a member of the calcitonin gene-related peptide family (5, 6).”
BackgroundOwji, A. A., Chabot, J., Dumont, Y., & Quirion, R. (2008) · Journal of Molecular Neuroscience · doi:10.1007/s12031-008-9062-x · Cited by 15
“Large amounts of immunoreactive AM2/IM were found in the stomach, kidneys, pituitary, and hypothalamus in the rat (Roh et al. 2004; Takei et al. 2004; Taylor et al. 2005).”
BackgroundResultInfluentialHirose, T., Totsune, K., 中繁由紀子, Metoki, H., Kikuya, M., Ohkubo, T., Hara, A., Satoh, M., Inoue, R., Asayama, K., et al. (2011) · Hypertension Research · doi:10.1038/hr.2011.131 · Cited by 15
REN, H., REN, H., LI, X., YU, D., MU, S., CHEN, Z., & FU, Q. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.4328 · Cited by 14
“Similar to other CT family members, including calcitonin gene-related peptide (CGRP) and AMD, IMD exerts its actions through receptor complexes comprising calcitonin receptor-like receptor (CRLR) and one of three receptor activity modifying proteins, (RAMP1, RAMP2 and RAMP3) (1,7), and stimulate the formation of cycli…”
Liao, H., Wan, S., Zhang, X., Shi, D., Zhu, X., & Chen, X. (2017) · Medical Science Monitor · doi:10.12659/msm.907298 · Cited by 14
“IMD is also a potent vasodilator by increasing cAMP production, and continuous IMD treatment decreases blood pressure and improves hemodynamic function in spontaneously hypertensive rats via the cAMP-PKA pathway [10,11,26,27].”
BackgroundTelli, G., Tel, B. C., Yersal, N., Korkusuz, P., & Gümüşel, B. (2017) · Life Sciences · doi:10.1016/j.lfs.2017.11.031 · Cited by 14
“Intermedin/adrenomedullin2 (IMD/AM2) is the latest member of the CGRP family; similar to other members of the family, IMD/AM2 has a significant effect on the cardiovascular system [13,14].”
BackgroundWang, Y., Mi, Y., Tian, J., Qiao, X., Su, X., Kang, J., Wu, Z., Wang, G., Zhou, X., Zhou, Y., et al. (2020) · Drug Design Development and Therapy · doi:10.2147/dddt.s253019 · Cited by 14
“of human tissues, such as the nervous system, heart, kidney, lung, gastrointestinal tract and thymus.(5,6) Our previous studies found that it could alleviate renal IRI in vivo and in vitro.”
BackgroundSu, Y., Guan, P., Li, D., Hang, Y., Ye, X., Han, L., Lü, Y., Bai, X., Zhang, P., & Hu, W. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.10.038 · Cited by 14
Terra, S. R., Cardoso, J. C. R., Félix, R. C., Martins, L. A. M., Souza, D. O., Guma, F. T. C. R., Canário, A. V. M., & Schein, V. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.01.010 · Cited by 16
“The CGRP receptor is a dimeric complex of CALCRL and RAMP1, needing the presence of both for peptide activation (Aiyar et al., 1996; McLatchie et al., 1998; Roh et al., 2004; Smillie and Brain, 2011).”
BackgroundIntermedin alleviates pathological cardiac remodeling by upregulating klotho
Zhang, L., Liu, Y., Chen, Y., Ren, J.-L., Zhang, Y.-R., Yu, Y.-R., Jia, M.-Z., Ning, Z., Du, J., Tang, C., et al. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104926 · Cited by 15
Adrenomedullin 2/intermedin-like immunoreactivity in the hypothalamus and brainstem of rats
Hashimoto, H., Kitamura, K., Kawasaki, M., Saito, T., Suzuki, H., Otsubo, H., Ohbuchi, T., Yokoyama, T., Fujihara, H., Takei, Y., et al. (2008) · Autonomic Neuroscience · doi:10.1016/j.autneu.2008.01.003 · Cited by 14
N-Procalcitonin: Central Effects on Feeding and Energy Homeostasis in Rats
Tavares, E., Maldonado, R., & Miñano, F. J. (2006) · Endocrinology · doi:10.1210/en.2006-0792 · Cited by 14
“Similar to other CT-like peptides such as intermedin (17), the effects of N-PCT on food intake appear to be independent of the effects on water intake.”
ResultAdrenomedullin2 (ADM2)/Intermedin (IMD): A Potential Role in the Pathophysiology of Preeclampsia
Chauhan, M., Balakrishnan, M. P., Vidaeff, A. C., Yallampalli, U., Lugo, F., Fox, K. A., Belfort, M. A., & Yallampalli, C. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1333 · Cited by 15
Sun, J., Jing, M.-Y., Wang, J. F., & Weng, X. Y. (2009) · Journal of Animal Physiology and Animal Nutrition · doi:10.1111/j.1439-0396.2009.00937.x · Cited by 17
“In terms of previous studies (McLatchie et al., 1998; Husmann et al., 2000; Roh et al., 2004), it may be speculated that CGRP promoted cAMP cumulation by binding to the G protein-coupled receptor and stimulation of cAMP/PKA pathway, and thereby caused reduction in food intake, in favour of the…”
Control of myeloid cell functions by nociceptors
Hanč, P., Messou, M.-A., Wang, Y., & von Andrian, U. H. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1127571 · Cited by 15
“The CGRP family of neuropeptides includes CGRPa (50) and CGRPb (51), which are thought to be functionally redundant (52), adrenomedullin (AM) (53), and intermedin (54) (also known as adrenomedullin 2 (AM2)).”
BackgroundGan, X.-B., Sun, H., Chen, D., Zhang, L., Zhou, Y., Chen, L., & Zhou, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094234 · Cited by 13
“The CRLR/RAMP1 complex forms the CGRP receptor, whereas CRLR/RAMP2 or CRLR/RAMP3 complex forms the AM receptor [10].”
BackgroundYang, X., Shao, H., Chen, Y., Ding, N., Yang, A., Tian, J., Jiang, Y., Li, G., & Jiang, Y. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.02.126 · Cited by 13
New Methods for Researching Accessory Proteins
Foord, S. M., Topp, S. D., Abramo, M., & Holbrook, J. D. (2005) · Journal of Molecular Neuroscience · doi:10.1385/jmn:26:2-3:265 · Cited by 14
“There are five of these peptides—calcitonin, calcitonin/calcitonin gene-related peptide (CGRP), adrenomedullin, amylin, and now adrenomedullin 2 (Roh et al., 2004; Takei et al., 2004).”
BackgroundInfluentialRAMP et récepteurs couplés aux protéines G
Cueille, C., & Garel, J. (2004) · médecine/sciences · doi:10.1051/medsci/2004208-9773 · Cited by 14
“L’identification en 2003 d’un nouveau peptide, l’intermédine, membre de la famille de la CT [41], a montré qu’il agissait par l’intermédiaire d’un récepteur constitué du CRLR et d’un RAMP, sans spécificité particulière pour l’un des trois RAMP.”
Effect of intermedin/adrenomedullin-2 on venous tone in conscious rats
Abdelrahman, A. M., & Pang, C. C. Y. (2006) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-006-0076-z · Cited by 13
“Intermedin/adrenomedullin-2 caused a depressor effect following intraperitoneal injection into rats (Roh et al. 2004) or intravenous injection into mice (Takei et al. 2004b).”
BackgroundInfluentialNeural Stem Cells in the Adult Brain: From Benchside to Clinic
González-Pérez, Ó., García‐Verdugo, J. M., Quiñones‐Hinojosa, A., Luquín, S., Gudiño‐Cabrera, G., & González-Castañeda, R. E. (2012) · Stem Cells International · doi:10.1155/2012/378356 · Cited by 13
“Intermedin, also named adrenomedullin 2, has also been identified as a novel member of this family [12, 13].”
BackgroundBenita, B. A., & Koss, K. M. (2024) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2024.1443985 · Cited by 13
Calcitonin receptor-mediated CFTR activation in human intestinal epithelial cells
Liu, H., Singla, A., Ao, M., Gill, R. K., Venkatasubramanian, J., Rao, M. C., Alrefai, W. A., & Dudeja, P. K. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01264.x · Cited by 12
“Calcitonin (CT) is a 32-amino acid peptide secreted from the parafollicular cells (C-cells) of the thyroid gland and belongs to a family of peptides including CT gene related peptide (CGRP), amylin, adrenomedullin, intermedin and CT receptor-stimulating peptide [1–4].”
BackgroundSustained Activation of CLR/RAMP Receptors by Gel-Forming Agonists
Chang, C. L., Cai, Z. P., & Hsu, S. Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113408 · Cited by 12
Self-citationBabin, K. M., Karim, J. A., Gordon, P. H., Lennon, J., Dickson, A., & Pioszak, A. A. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.104785 · Cited by 12
“AM2/IMD is thought to be relatively nonselective for the three CLR–RAMP complexes (1).”
Amylin(1–8) is Devoid of Anabolic Activity in Bone
Ellegaard, M., Thorkildsen, C., Petersen, S., Petersen, J. S., Jørgensen, N. R., Just, R., Schwarz, P., Ramírez, M. T., & Stahlhut, M. (2010) · Calcified Tissue International · doi:10.1007/s00223-010-9338-3 · Cited by 14
“Amylin belongs to an expanding family of peptides comprising calcitonin, calcitonin gene-related peptides (CGRPa and b), adrenomedullin, and intermedin (adrenomedullin 2) [17, 24].”
BackgroundPlasma intermedin levels in patients with acute myocardial infarction
Lv, Z., Wu, K., Chen, X., Zhang, X., & Hong, B. (2013) · Peptides · doi:10.1016/j.peptides.2013.03.007 · Cited by 12
Otsubo, H., Hyodo, S., Hashimoto, H., Kawasaki, M., Suzuki, H., Saito, T., Ohbuchi, T., Yokoyama, T., Fujihara, H., Matsumoto, T., et al. (2009) · Journal of Endocrinology · doi:10.1677/joe-09-0009 · Cited by 12
Effects of intermedin1-53 on myocardial fibrosis
Yang, X., Zhang, H., Jia, Y.-X., Ni, L., Li, G., Xue, L., & Jiang, Y. (2012) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gms093 · Cited by 12
Chen, K., Yan, M., Li, Y., Dong, Z., Huang, D., Li, J., & Wei, M. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.6193 · Cited by 12
“It has previously been reported that IMD1-53 increased total NOS activity, but had little effect on mRNA levels of either inducible NOS or eNOS in the rat aorta (16).”
BackgroundExperimental study on renoprotective effect of intermedin on diabetic nephropathy
Wang, Y., Tian, J., Mi, Y., Ren, X., Lian, S., Kang, J., Wang, J., Zang, H., Wu, Z., Yang, J. H., et al. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111224 · Cited by 12
Hemodynamic, Hormonal, and Renal Actions of Adrenomedullin 2 in Experimental Heart Failure
Rademaker, M. T., Charles, C. J., Nicholls, M. G., & Richards, M. (2008) · Circulation Heart Failure · doi:10.1161/circheartfailure.107.755504 · Cited by 12
Cui, H., Kohsaka, A., Waki, H., Gouraud, S. S., Nakamura, T., Yukawa, K., Hatada, A., Bhuiyan, M. E. R., & Maeda, M. (2008) · Autonomic Neuroscience · doi:10.1016/j.autneu.2008.07.009 · Cited by 12
“Indeed, several studies have revealed that circulating AM2 directly regulates venous tone to maintain arterial pressure in rodents (Abdelrahman and Pang, 2006; Fujisawa et al., 2006; Roh et al., 2004).”
InfluentialGPCRs as potential therapeutic targets in preeclampsia
McGuane, J. T., & Conrad, K. P. (2012) · Drug Discovery Today Disease Models · doi:10.1016/j.ddmod.2012.05.001 · Cited by 12
“The calcitonin receptor-like receptor (CRLR) GPCR mediates transmembrane signalling for three non-allelic vasodilatory peptides: calcitonin gene-related peptide (CGRP), adrenomedullin, and intermedin [18].”
Arkless, K. L., Argunhan, F., & Brain, S. D. (2018) · Handbook of experimental pharmacology · doi:10.1007/164_2018_129 · Cited by 12
Sexton, P. M., Poyner, D. R., Simms, J., Christopoulos, A., & Hay, D. L. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-2364-5_6 · Cited by 15
Potentiated response to adrenomedullin in myocardia and aortas in spontaneously hypertensive rat
Pan, C. S., Jiang, W., Wu, S. Y., Zhao, J., Pang, Y., Tang, C. S., & Qi, Y. (2006) · Basic Research in Cardiology · doi:10.1007/s00395-005-0583-y · Cited by 12
New biomarkers and heart failure
Vondráková, D., Málek, F., Ošťádal, P., Krüger, A., & Neužil, P. (2013) · Cor et Vasa · doi:10.1016/j.crvasa.2013.04.003 · Cited by 11
Ogoshi, M., Kato, K., & Sakamoto, T. (2015) · Zoological Letters · doi:10.1186/s40851-015-0012-5 · Cited by 11
“AM2 was also identified at the same time by another group, and named intermedin [5].”
BackgroundPires, A. L., Pinho, M., Sena, C. M., Seiça, R. M. F., & Leite-Moreira, A. F. (2012) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00877.2011 · Cited by 11
Kim, J. T., Lim, M. A., Lee, S. E., Kim, H. J., Koh, H. Y., Lee, J. H., Jun, S. M., Kim, J., Kim, K. H., Shin, H. S., et al. (2022) · The Journal of Pathology · doi:10.1002/path.5997 · Cited by 11
Bell, D., Zhao, Y. Y., Devine, A. B., & McDermott, B. J. (2008) · Cellular Physiology and Biochemistry · doi:10.1159/000113870 · Cited by 11
Chauhan, M., Balakrishnan, M. P., Blesson, C. S., & Yallampalli, C. (2014) · Biology of Reproduction · doi:10.1095/biolreprod.113.112854 · Cited by 11
“Previous studies showed that ADM2 has vasodilatory and hypotensive actions that were similar to or more potent than those of ADM and CALCB [1, 3].”
BackgroundResultInfluentialChauhan, M., Betancourt, A., Balakrishnan, M. P., Mishra, A., Espinosa, J., Shamshirsaz, A. A., Fox, K. A., Belfort, M. A., & Yallampalli, C. (2021) · Endocrinology · doi:10.1210/endocr/bqab204 · Cited by 11
Fu, Y., Létourneau, M., Nguyen, Q. T., Chatenet, D., Dupuis, J., & Fournier, A. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.06.031 · Cited by 11
Evidence of Involvement of the Calcitonin Gene‐Related Peptide in Restless Legs Syndrome
Mogavero, M. P., Fowowe, M., Sanni, A., Goli, M., Lanza, G., L’Episcopo, F., Ferini‐Strambi, L., Mechref, Y. S., & Ferri, R. (2025) · Movement Disorders · doi:10.1002/mds.30125 · Cited by 10
Dong, Y.-L., Chauhan, M., Belfort, M. A., & Yallampalli, C. (2016) · Biology of Reproduction · doi:10.1095/biolreprod.116.143529 · Cited by 10
“Elevated levels of CALCB [16–18], ADM [16, 17, 19], as well as ADM2 [7, 20] are associated with rat and human pregnancy.”
BackgroundKong, L., Xiong, Y., Wang, D., Huang, L., Li, M., Feng, Z., Zhou, Y., Zhang, H., Liu, F., Xiao, F., et al. (2022) · Breast Cancer Research and Treatment · doi:10.1007/s10549-022-06687-0 · Cited by 12
“In our previous study, we have identified an IMD/CRLR/βarrestin 1/Src signaling cascade in endothelial cells [29]. β-arrestin 1 is a scaffold protein that mediates the agonistdependent recruitment of Src kinase to GPCRs [30, 31].”
BackgroundInfluentialVariable CGRP family peptide signaling durations and the structural determinants thereof
Babin, K. M., Gostynska, S. E., Karim, J. A., & Pioszak, A. A. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116235 · Cited by 10
Protective effect of intermedin on myocardial cell in a rat model of severe acute pancreatitis
Du, X., Cao, Y., Xue, P., Lin, Z., Zeng, Z., & Xia, Q. (2011) · Cellular & Molecular Biology Letters · doi:10.2478/s11658-011-0020-1 · Cited by 10
“IMD belongs to the calcitonin generelated peptide (CGRP) / adrenomedullin (ADM) family and is a potent endogenous cardio-renal-protective substance [13].”
BackgroundInfluentialIncrease of CGRP-Containing Nerve Fibers in the Rat Periodontal Ligament After Luxation
Nagayama, T., Seiryu, M., Deguchi, T., Kano, M., Suzuki, T., Takano‐Yamamoto, T., & Ichikawa, H. (2011) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-011-9767-1 · Cited by 11
“Heterodimers of calcitonin receptor with RAMP1, RAMP2, and RAMP3 exhibit the pharmacological profiles of receptors specific for amylin (Roh et al. 2004).”
BackgroundUbiquitous expression and multiple functions of biologically active peptides
Takahashi, K., Ohba, K., & Kaneko, K. (2015) · Peptides · doi:10.1016/j.peptides.2015.04.004 · Cited by 10
Effect of Intermedin1-53 on Angiotensin II-Induced Hypertrophy in Neonatal Rat Ventricular Myocytes
Yang, J., Ma, C., Cai, Y., Pan, C., Zhao, J., Tang, C., & Qi, Y. (2010) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e3181ddc785 · Cited by 10
“For example, some studies revealed that intraperitoneal, intravenous, or intracerebroventricular administration of IMD increases the heart rate.(1,2,4,7) Initial works from our laboratory(5,8) and other groups(9) have demonstrated that IMD1–53 dilates coronary arteries, enhances coronary flow in isolated perfused rat…”
BackgroundResultChauhan, M., Yallampalli, U., Banadakappa, M., & Yallampalli, C. (2015) · Biology of Reproduction · doi:10.1095/biolreprod.115.134585 · Cited by 10
Xu, B., Xu, H., Cao, H., Liu, X., Qin, C., Zhao, Y., Han, X., & Li, H. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.6776 · Cited by 10
“Intermedin (IMD) is a novel member of the calcitonin gene-related peptide (CGRP) family, signaling via calcitonin receptor-like receptor/receptor activity modifying protein (CRLR/RAMP) complexes (10).”
CRIF1 deficiency suppresses endothelial cell migration via upregulation of RhoGDI2
Nagar, H., Kim, S., Lee, I., Choi, S., Piao, S., Jeon, B. H., Shong, M., & Kim, C. (2021) · PLoS ONE · doi:10.1371/journal.pone.0256646 · Cited by 10
“They are cardiovascular polypeptides and brain-gut peptides of the CGRP superfamily, and composed of 47 amino acids [20].”
BackgroundInfluentialRegulation of RAMP Expression in Diseases
Jacob, A., Wu, R., & Wang, P. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-2364-5_8 · Cited by 10
Novel Regulators of Hemodynamics in the Pregnant Uterus
Clark, N. C., Pru, C. A., & Pru, J. K. (2017) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2016.12.007 · Cited by 10
“Similarly, adrenomedullin 2 (ADM2), otherwise known as intermedin (IMD), is a vasodilator that signals through the CRLR/RAMP receptor complex.(87) ADM2 facilitates trophoblast invasion into the decidua”
BackgroundIntermedin restricts vessel sprouting by inhibiting the loosening of endothelial junction
Xiao, F., Wang, L., Zhao, H., Chun, T., Wang, D., Zhang, H., Wei, Y., Liu, J., & Zhang, W. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.01.090 · Cited by 9
Cabiati, M., Sabatino, L., Svezia, B., Raffaele, C., Verde, A., Caselli, C., Prescimone, T., Giannessi, D., & Silvia, D. R. (2014) · Peptides · doi:10.1016/j.peptides.2014.01.028 · Cited by 9
Receptor-Mediated Events in the Microcirculation
Watts, S. W., Kanagy, N. L., & Lombard, J. H. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-374530-9.00007-3 · Cited by 14
Metadata
- Authors
- Roh, J., Chang, C. L., Bhalla, A., Klein, C., & Hsu, S. Y. T.
- Affiliations
- Stanford Medicine (US)
- Corresponding author
- Hsu, Sheau Yu Teddy
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2004-02
- Volume
- 279
- Issue
- 8
- Pages
- 7264-7274
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2044285853
- Cited by
- 443
- References
- 37
- Citations by year
- 2026: 4 · 2025: 7 · 2024: 7 · 2023: 12 · 2022: 15 · 2021: 16 · 2020: 17 · 2019: 15 · 2018: 22 · 2017: 25 · 2016: 23 · 2015: 20 · 2014: 22 · 2013: 24 · 2012: 24
- FWCI
- 10.67
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6102 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- School of Medicine, Stanford University
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Sensory Systems › Ion Channels and Receptors
- Health Sciences › Medicine › Clinical Neurology › Migraine and Headache Studies
- Keywords
- intermedin, calcitonin gene-related peptide, calcitonin, adrenomedullin, amylin, calcitonin receptor-like receptor, receptor activity-modifying proteins, RAMP1, RAMP2, RAMP3, cAMP signaling, blood pressure regulation, hypertension, gastric emptying, dietary intake, pituitary gland, gastrointestinal tract
- MeSH terms
- Cyclic AMP, Amino Acid Sequence, Animals, Base Sequence, Blood Pressure, Calcitonin, Cell Line, Cloning, Molecular, Dose-Response Relationship, Drug, Humans, Male, Mice, Inbred C57BL, Molecular Sequence Data, Peptides, Phylogeny, Protein Binding, Rats, Inbred SHR, Time Factors, Tissue Distribution, Transfection, Blotting, Northern, Signal Transduction, Calcitonin Gene-Related Peptide, Rats, Sprague-Dawley, Sequence Homology, Amino Acid, Receptors, Calcitonin Gene-Related Peptide, DNA, Complementary, Peptide Hormones, Cell Line, Tumor, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.